24-Hour blood pressure response to lower dose (30 mg) fimasartan in Korean patients with mild to moderate essential hypertension

BACKGROUND/AIMS: Fimasartan is an angiotensin type 1 receptor blocker (ARB) which has comparable efficacy and tolerability with other ARBs. The aim of this study was to evaluate 24-hour blood pressure (BP) lowering efficacy and the tolerability of the low dose fimasartan compared with valsartan in p...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Hae-Young, Kim, Cheol-Ho, Song, Jae-Kwan, Chae, Shung Chull, Jeong, Myung Ho, Kim, Dong-Soo, Oh, Byung-Hee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association of Internal Medicine 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5668394/
https://www.ncbi.nlm.nih.gov/pubmed/29032666
http://dx.doi.org/10.3904/kjim.2016.094

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5668394/
https://www.ncbi.nlm.nih.gov/pubmed/29032666
http://dx.doi.org/10.3904/kjim.2016.094

Ejemplares similares